|
1 | 1 | guid kind label part_of is_a |
2 | | -000c0001-c3fa-ec2a-f72a-fbd6cb3779b9 gene CYP2C9 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C9 entity / gene |
3 | | -000c0001-c3fa-ec2a-f72a-1066f93779b9 gene CYP2D6 pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 entity / gene |
4 | | -000c0001-c3fa-1b2a-982a-61ef4f3779b9 gene HLA-B pharmacogenome / HLA / HLA-B entity / gene |
5 | | -000c0001-c3fa-ec2a-f72a-d69bfe3779b9 gene CYP2C19 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 entity / gene |
6 | | -000c0001-c3fa-f92a-8f2a-ec80083779b9 gene TPMT pharmacogenome / TPMT / TPMT entity / gene |
7 | | -000c0002-c358-ec6f-f76f-d69bfe4cda56 allele CYP2C19 *4 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 / 4 allele / no_function |
8 | | -000c0002-c358-ec6f-f76f-1066f96f7ace allele CYP2D6 *4 pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / 4 allele / no_function |
9 | | -000c0002-c358-1bd5-98d5-61ef4f6ef372 allele HLA-B *57:01 pharmacogenome / HLA / HLA-B / 57_01 allele / uncertain_function |
10 | | -000c0002-c358-ec6f-f76f-d69bfe558274 allele CYP2C19 *2 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 / 2 allele / no_function |
11 | | -000c0002-c358-ecd8-f7d8-fbd6cbd5c622 allele CYP2C9 *2 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C9 / 2 allele / decreased_function |
12 | | -000c0002-c358-ec07-f707-d69bfe3c1176 allele CYP2C19 *1 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 / 1 allele / normal_function |
13 | | -000c0002-c358-ec6f-f76f-fbd6cb6b6a6d allele CYP2C9 *3 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C9 / 3 allele / no_function |
14 | | -000c0002-c358-ec07-f707-1066f9fd85b3 allele CYP2D6 *1 pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / 1 allele / normal_function |
15 | | -000c0004-c347-ecb1-f7b1-1066f93779b9 phenotype CYP2D6 Ultrarapid Metabolizer pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / phenotypes / ultrarapid_metabolizer phenotype / ultrarapid_metabolizer |
16 | | -000c0004-c347-ecb1-f7b1-1066f96ef372 phenotype CYP2D6 Ultrarapid Metabolizer pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / phenotypes / ultrarapid_metabolizer phenotype / ultrarapid_metabolizer |
17 | | -000c0004-c347-ec7a-f77a-1066f9a66d2b phenotype CYP2D6 Normal Metabolizer pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / phenotypes / normal_metabolizer phenotype / normal_metabolizer |
18 | | -000c0004-c347-f9a8-8fa8-ec80083779b9 phenotype TPMT Intermediate Metabolizer pharmacogenome / TPMT / TPMT / phenotypes / intermediate_metabolizer phenotype / intermediate_metabolizer |
19 | | -000c0004-c347-f9e9-8fe9-ec80086ef372 phenotype TPMT Poor Metabolizer pharmacogenome / TPMT / TPMT / phenotypes / poor_metabolizer phenotype / poor_metabolizer |
20 | | -000c0004-c347-f9db-8fdb-ec8008a66d2b phenotype TPMT Indeterminate pharmacogenome / TPMT / TPMT / phenotypes / indeterminate phenotype / indeterminate |
21 | | -000c0005-c3af-cb3e-233c-1c839f6ef372 drug abacavir pharmacogenome / drugs / abacavir drug / J / J05 / J05A / J05AF / abacavir |
22 | | -000c0005-c3af-cb0a-630d-1c7cd36ef372 drug amitriptyline pharmacogenome / drugs / amitriptyline drug / N / N06 / N06A / N06AA / amitriptyline |
23 | | -000c0005-c3af-cba6-3010-1c9137a66d2b drug warfarin pharmacogenome / drugs / warfarin drug / B / B01 / B01A / B01AA / warfarin |
24 | | -000c0005-c3af-cba6-b610-1c9137bbcdc8 drug clopidogrel pharmacogenome / drugs / clopidogrel drug / B / B01 / B01A / B01AC / clopidogrel |
25 | | -000c0006-c7ee-454c-db4c-a2917a3779b9 recommendation g100421 RxNorm:190521 [HLA-B:*57:01 negative] -> Strong recommendations / g100421 / rxnorm_190521 recommendation / strong |
26 | | -000c0006-c7ee-454c-db4c-a2917a6ef372 recommendation g100421 RxNorm:190521 [HLA-B:*57:01 positive] -> Strong recommendations / g100421 / rxnorm_190521 recommendation / strong |
| 2 | +0e010001-c3fa-ec2a-f72a-fbd6cb3779b9 gene CYP2C9 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C9 entity / gene |
| 3 | +0e010001-c3fa-ec2a-f72a-1066f93779b9 gene CYP2D6 pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 entity / gene |
| 4 | +0e010001-c3fa-1b2a-982a-61ef4f3779b9 gene HLA-B pharmacogenome / HLA / HLA-B entity / gene |
| 5 | +0e010001-c3fa-ec2a-f72a-d69bfe3779b9 gene CYP2C19 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 entity / gene |
| 6 | +0e010001-c3fa-f92a-8f2a-ec80083779b9 gene TPMT pharmacogenome / TPMT / TPMT entity / gene |
| 7 | +0e010002-c358-ec6f-f76f-d69bfe4cda56 allele CYP2C19 *4 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 / 4 allele / no_function |
| 8 | +0e010002-c358-ec6f-f76f-1066f96f7ace allele CYP2D6 *4 pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / 4 allele / no_function |
| 9 | +0e010002-c358-1bd5-98d5-61ef4f6ef372 allele HLA-B *57:01 pharmacogenome / HLA / HLA-B / 57_01 allele / uncertain_function |
| 10 | +0e010002-c358-ec6f-f76f-d69bfe558274 allele CYP2C19 *2 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 / 2 allele / no_function |
| 11 | +0e010002-c358-ecd8-f7d8-fbd6cbd5c622 allele CYP2C9 *2 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C9 / 2 allele / decreased_function |
| 12 | +0e010002-c358-ec07-f707-d69bfe3c1176 allele CYP2C19 *1 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C19 / 1 allele / normal_function |
| 13 | +0e010002-c358-ec6f-f76f-fbd6cb6b6a6d allele CYP2C9 *3 pharmacogenome / CYP / CYP2 / CYP2C / CYP2C9 / 3 allele / no_function |
| 14 | +0e010002-c358-ec07-f707-1066f9fd85b3 allele CYP2D6 *1 pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / 1 allele / normal_function |
| 15 | +0e010004-c347-ecb1-f7b1-1066f93779b9 phenotype CYP2D6 Ultrarapid Metabolizer pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / phenotypes / ultrarapid_metabolizer phenotype / ultrarapid_metabolizer |
| 16 | +0e010004-c347-ecb1-f7b1-1066f96ef372 phenotype CYP2D6 Ultrarapid Metabolizer pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / phenotypes / ultrarapid_metabolizer phenotype / ultrarapid_metabolizer |
| 17 | +0e010004-c347-ec7a-f77a-1066f9a66d2b phenotype CYP2D6 Normal Metabolizer pharmacogenome / CYP / CYP2 / CYP2D / CYP2D6 / phenotypes / normal_metabolizer phenotype / normal_metabolizer |
| 18 | +0e010004-c347-f9a8-8fa8-ec80083779b9 phenotype TPMT Intermediate Metabolizer pharmacogenome / TPMT / TPMT / phenotypes / intermediate_metabolizer phenotype / intermediate_metabolizer |
| 19 | +0e010004-c347-f9e9-8fe9-ec80086ef372 phenotype TPMT Poor Metabolizer pharmacogenome / TPMT / TPMT / phenotypes / poor_metabolizer phenotype / poor_metabolizer |
| 20 | +0e010004-c347-f9db-8fdb-ec8008a66d2b phenotype TPMT Indeterminate pharmacogenome / TPMT / TPMT / phenotypes / indeterminate phenotype / indeterminate |
| 21 | +0e010005-c3af-cb3e-233c-1c839f6ef372 drug abacavir pharmacogenome / drugs / abacavir drug / J / J05 / J05A / J05AF / abacavir |
| 22 | +0e010005-c3af-cb0a-630d-1c7cd36ef372 drug amitriptyline pharmacogenome / drugs / amitriptyline drug / N / N06 / N06A / N06AA / amitriptyline |
| 23 | +0e010005-c3af-cba6-3010-1c9137a66d2b drug warfarin pharmacogenome / drugs / warfarin drug / B / B01 / B01A / B01AA / warfarin |
| 24 | +0e010005-c3af-cba6-b610-1c9137bbcdc8 drug clopidogrel pharmacogenome / drugs / clopidogrel drug / B / B01 / B01A / B01AC / clopidogrel |
| 25 | +0e010006-c7ee-454c-db4c-a2917a3779b9 recommendation g100421 RxNorm:190521 [HLA-B:*57:01 negative] -> Strong recommendations / g100421 / rxnorm_190521 recommendation / strong |
| 26 | +0e010006-c7ee-454c-db4c-a2917a6ef372 recommendation g100421 RxNorm:190521 [HLA-B:*57:01 positive] -> Strong recommendations / g100421 / rxnorm_190521 recommendation / strong |
0 commit comments